Based on TCGA and International Cancer Genome Consortium (ICGC) cohorts, DYSF, VNN3, TMED3, and TEK were found and validated to exert as promising biomarkers to predict the prognosis of ccRCC patients [30–33]. The gene discussed is TMED3; the disease is nonpapillary renal cell carcinoma.